Crystal structure of wdr5 in complex with triazole-based inhibitors Deposition Author(s): Goins, C.M. , Stauffer, S.R.
Date: 2025-02-17 Method: X-RAY DIFFRACTION Resolution: 1.58 Å Organism(s): Homo Sapiens Sequences Data: 9NCW_A , 9NCW_B , 9NCW_C , 9NCW_D
Structure of sars-cov-2 nsp14 bound to n-((4-cyclopropylthiazol-2-yl)methyl)-1h-pyrazole-3-carboxamide Deposition Author(s): Coker, J.A. , Jung, J. , Polzer, P.M. , Stauffer, S.R. , Sun, R.
Date: 2025-02-21 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NFP_A
Structure of sars-cov-2 nsp14 bound to n-((4-isopropylthiazol-2-yl)methyl)-1h-pyrazole-3-carboxamide Deposition Author(s): Coker, J.A. , Jung, J. , Polzer, P.M. , Stauffer, S.R. , Sun, R.
Date: 2025-02-24 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NHA_A
Structure of sars-cov-2 nsp14 bound to 5-(((cyclopropylmethyl)amino)methyl)-n-((4-cyclopropylthiazol-2-yl)methyl)-1h-pyrazole-3-carboxamide Deposition Author(s): Coker, J.A. , Jung, J. , Polzer, P.M. , Stauffer, S.R. , Sun, R.
Date: 2025-02-25 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NHU_A
Sars-cov-2 nsp14 bound to n-((2-ethynylthiazol-4-yl)methyl)-1h-pyrazole-3-carboxamide Deposition Author(s): Coker, J.A. , Jung, J. , Polzer, P.M. , Stauffer, S.R. , Sun, R.
Date: 2025-02-26 Method: X-RAY DIFFRACTION Resolution: 2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NIO_A
Structure of sars-cov-2 nsp14 bound to n-((4-cyclopropylthiazol-2-yl)methyl)-1h-pyrazolo[3,4-b]pyridine-3-carboxamide Deposition Author(s): Coker, J.A. , Jung, J. , Polzer, P.M. , Stauffer, S.R. , Sun, R.
Date: 2025-02-27 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NJG_A
Sars-cov-2 3clpro in complex with 3-(6-bromo-2-hydroxy-3-(isoquinolin-4-yl)-4-oxoquinolin-1(4h)-yl)propanenitrile Deposition Author(s): Goins, C.M. , Stauffer, S.R.
Date: 2025-03-04 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NMC_A
Sars-cov-2 3clpro in complex with 3-(6-bromo-2-hydroxy-3-(isoquinolin-4-yl)-4-oxoquinolin-1(4h)-yl)propanenitrile Deposition Author(s): Goins, C.M. , Stauffer, S.R.
Date: 2025-03-04 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NMD_A
Sars-cov-2 3clpro in complex with 2-[2-hydroxy-3-(4-isoquinolyl)-4-oxo-6-(trifluoromethyl)-1h-quinolin-8-yl]benzonitrile Deposition Author(s): Goins, C.M. , Stauffer, S.R.
Date: 2025-03-04 Method: X-RAY DIFFRACTION Resolution: 1.6 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NME_A
Sars-cov-2 3clpro in complex with 8-(6-amino-3-pyridyl)-2-hydroxy-3-(4-isoquinolyl)-6-(trifluoromethyl)-1h-quinolin-4-one Deposition Author(s): Goins, C.M. , Stauffer, S.R.
Date: 2025-03-04 Method: X-RAY DIFFRACTION Resolution: 1.8 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9NMF_A , 9NMF_B